Stefan Borgwardt Selected Research

Stefan Borgwardt Research Topics

Disease

66	Psychotic Disorders (Schizoaffective Disorder) 04/2024 - 04/2009
24	Schizophrenia (Dementia Praecox) 04/2024 - 10/2010
6	Mental Disorders (Mental Disorder) 06/2022 - 12/2013
6	Heroin Dependence (Heroin Abuse) 12/2015 - 01/2013
5	Major Depressive Disorder (Major Depressive Disorders) 01/2023 - 01/2018
3	Borderline Personality Disorder (Personality Disorders, Borderline) 01/2023 - 01/2021
3	Opioid-Related Disorders (Opiate Addiction) 01/2021 - 01/2021
3	Mood Disorders (Mood Disorder) 01/2021 - 07/2015
3	Personality Disorders (Personality Disorder) 01/2021 - 09/2019
3	Treatment-Resistant Depressive Disorder 01/2020 - 12/2013
2	Cognitive Dysfunction 01/2023 - 10/2014
2	Substance-Related Disorders (Drug Abuse) 01/2021 - 01/2015
2	Hallucinations (Hallucination) 01/2021 - 10/2015
2	Obesity 01/2015 - 01/2013
1	Neurobehavioral Manifestations 11/2023
1	COVID-19 11/2023
1	Syndrome (Syndromes) 01/2022
1	Infections 01/2022
1	Stroke (Strokes) 11/2021
1	Depressive Disorder (Melancholia) 11/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2021
1	Paranoid Schizophrenia (Delusional Disorder) 01/2021
1	Anhedonia 01/2021
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2021
1	Sleepiness 01/2020
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020
1	Erythema 12/2019
1	Morbid Obesity 01/2019
1	Fatty Liver 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2017
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2017
1	Chronic Disease (Chronic Diseases) 01/2017
1	Sleep Wake Disorders 11/2016
1	Synesthesia 10/2015
1	Dementia (Dementias) 10/2014
1	Multiple Sclerosis 07/2013
1	Fatigue 07/2013
1	Brain Diseases (Brain Disorder) 01/2013
1	Atherosclerosis 01/2013

Drug/Important Bio-Agent (IBA)

37	Polytetrafluoroethylene (Teflon)FDA Link 04/2024 - 10/2010
19	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2012
16	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 10/2010
6	Lysergic Acid Diethylamide (LSD)IBA 06/2022 - 10/2015
6	Heroin (Diamorphine)IBA 01/2021 - 01/2013
5	Antidepressive Agents (Antidepressants)IBA 01/2021 - 12/2013
4	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2020 - 01/2017
3	Cholinergic Agents (Cholinergics)IBA 11/2023 - 12/2021
3	Hallucinogens (Psychedelics)IBA 01/2022 - 01/2018
3	Cocaine (Cocaine HCl)IBA 01/2021 - 01/2021
3	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 05/2017
3	Opioid Analgesics (Opioids)IBA 01/2021 - 01/2012
3	Dronabinol (THC)FDA LinkGeneric 01/2021 - 04/2009
2	Ketamine FDA LinkGeneric 01/2023 - 01/2017
2	CannabidiolIBA 01/2021 - 01/2021
2	Caffeine (No Doz)FDA LinkGeneric 01/2021 - 01/2020
2	Complement System Proteins (Complement)IBA 01/2021 - 05/2017
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020 - 01/2017
2	Prednisolone (Predate)FDA LinkGeneric 01/2019 - 06/2012
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019 - 12/2013
2	Glutamic Acid (Glutamate)FDA Link 01/2018 - 01/2017
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2017 - 01/2017
2	LithiumIBA 01/2017 - 12/2013
1	Cholinergic Antagonists (Anticholinergics)IBA 11/2023
1	Psychotropic Drugs (Psychoactive Drugs)IBA 11/2023
1	Psilocybin (Psilocibin)IBA 06/2022
1	N 30IBA 01/2022
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 11/2021
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2021
1	Nootropic Agents (Nootropics)IBA 01/2021
1	Dopamine Agents (Dopaminergic Agents)IBA 01/2021
1	SolutionsIBA 01/2021
1	MelatoninIBA 01/2020
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2020
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2020
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2020
1	Histamine (Histamine Dihydrochloride)FDA Link 12/2019
1	Olanzapine (Zyprexa)FDA Link 01/2019
1	Nerve Growth Factors (Neurotrophins)IBA 01/2019
1	Uvitex SWN (SWN)IBA 08/2018
1	Therapeutic UsesIBA 01/2018
1	Minocycline (Cyclops)FDA LinkGeneric 05/2017
1	Amyloid (Amyloid Fibrils)IBA 01/2017
1	GLYX-13 peptideIBA 01/2017
1	TeaIBA 10/2014
1	nitazoxanide (NTZ)FDA Link 07/2013
1	Natalizumab (Tysabri)FDA Link 07/2013
1	EndocannabinoidsIBA 01/2013
1	Insulin-Like PeptidesIBA 01/2013
1	Gastrin-Releasing PeptideIBA 01/2013
1	GhrelinIBA 01/2013

Therapy/Procedure

5	Therapeutics 01/2023 - 01/2015
2	Cognitive Training 01/2024 - 01/2021
1	Fecal Microbiota Transplantation 01/2022
1	Injections 01/2021
1	Bariatric Surgery 01/2019
1	Duration of Therapy 01/2017
1	Phototherapy (Light Therapy) 11/2016
1	Ambulatory Care (Outpatient Care) 11/2014
1	Glycemic Control 01/2013